The start of the '20s offers the industry an opportunity to build value through new tech., collaborations, clinical validations, and value-based outcomes.
One of the latest concerns—arising from an old issue—is the medical device tax, which could return next year without legislative intervention before then.
Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors10.08.19